Comella, P., Massidda, B., Natale, D., Putzu, C., Sandomenico, C., Filippelli, G., et al. (2011). Efficacy and tolerability of biweekly bevacizumab, irinotecan, folinic acid and fluorouracil intravenous bolus (BIFF Regimen) in patients with metastatic colorectal cancer: the southern Italy cooperative oncology group experience. CLINICAL COLORECTAL CANCER, 10 (1), 42-47.

Efficacy and tolerability of biweekly bevacizumab, irinotecan, folinic acid and fluorouracil intravenous bolus (BIFF Regimen) in patients with metastatic colorectal cancer: the southern Italy cooperative oncology group experience

PALMERI, Sergio;
2011

Comella, P., Massidda, B., Natale, D., Putzu, C., Sandomenico, C., Filippelli, G., et al. (2011). Efficacy and tolerability of biweekly bevacizumab, irinotecan, folinic acid and fluorouracil intravenous bolus (BIFF Regimen) in patients with metastatic colorectal cancer: the southern Italy cooperative oncology group experience. CLINICAL COLORECTAL CANCER, 10 (1), 42-47.
File in questo prodotto:
File Dimensione Formato  
BIFF (Clin Colorectal Cancer 2011) phase II trial.pdf

Solo gestori archvio

Dimensione 865.33 kB
Formato Adobe PDF
865.33 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/10447/59452
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 1
social impact